GETUG16_2: GETUG16, figure 2

In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials

GETUG16, figure 2

Description

Kaplan-Meier digitized data from GETUG16, figure 2 (PMID 27160475). A reported sample size of 743 for a primary endpoint of PFS in prostate cancer.

Usage

GETUG16_2

Format

A data frame of 730 observations and 3 variables:

	time	event time (in months)
	event	PFS event indicator (0: no event, 1: event)
	arm	treatment arms (rt, rt_goserelin)

Source

Carrie C, Hasbini A, de Laroche G, et al. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Lancet Oncol 2016; 17: 747–56.

Examples

summary(GETUG16_2)

kmplot(GETUG16_2)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.